10-Q: China Foods Holdings Q1 2026 Financial Results
Quarterly Report
China Foods Holdings reports a net loss of $61,597 for the first quarter of 2026, supported by ongoing financial backing from its controlling shareholder.
Summary
- Reported revenue of $253 for Q1 2026, compared to $41 in Q1 2025.
- Net loss narrowed to $61,597 from $103,555 in the prior year period.
- Operating expenses decreased to $61,827 from $103,766, attributed to effective cost control.
- Cash and cash equivalents stood at $9,806 as of March 31, 2026.
- Current liabilities of $1,542,944 significantly exceed current assets of $163,956.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a distressed financial situation characterized by minimal revenue, significant accumulated deficits, and a reliance on shareholder support to maintain operations.
Positives
- Net loss reduced by approximately 40% compared to the same period in 2025.
- Gross profit margin improved to 91% from 61% in the prior year period.
- Management has secured unconditional financial support from the controlling shareholder to ensure going concern status for at least 12 months.
Negatives
- Extremely low revenue base of $253 for the quarter.
- Significant working capital deficit with current liabilities exceeding current assets by over $1.37 million.
- Accumulated deficit reached $2,591,813.
- Disclosure controls and procedures were deemed ineffective by management.
Risks
- Substantial doubt regarding long-term viability without continued shareholder financial support.
- Regulatory and legal uncertainties regarding operations in China and potential government intervention.
- Risk of delisting from U.S. markets due to the Holding Foreign Companies Accountable Act (HFCAA).
- High concentration of revenue and vendor reliance, with two customers accounting for 100% of revenue.
- Limited trading volume and liquidity for common stock.
Future Outlook
Management expects to continue relying on financial support from existing stockholders and private placements to fund operations and future acquisitions, while monitoring trade tensions and supply chain risks.
Management Comments
- Management believes that current cash and other sources of liquidity are adequate to support general operations for at least the next 12 months.
- The company is actively monitoring trade tensions and implementing strategies such as supplier diversification and local sourcing to mitigate impacts.
Industry Context
StockSavvy.ai notes that the company operates as a micro-cap entity in the highly competitive Chinese health and wellness sector, facing significant regulatory headwinds and operational scale challenges compared to larger, established competitors.
Comparison to Industry Standards
- Revenue levels are negligible compared to industry peers in the health and wellness space.
- The company's reliance on shareholder loans for working capital is atypical for mature, publicly traded companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Auditor Change | Resignation of J&S Associate PLT and engagement of BZ CPA Inc. | 2026-03-20 | Necessary for compliance with PCAOB requirements. |
Legal Proceedings
- None reported.
Related Party Transactions
- The company owes $494,507 to directors, $370,369 to a related company, and $398,583 to a related party as of March 31, 2026.
Stakeholder Impact
- Shareholders face significant dilution risk if private placements are utilized for capital.
- Creditors and related parties are currently providing the primary liquidity for the company.
Next Steps
- Continue operations through the subsidiary Guangzhou Xiao Xiang Health Industry Company Limited.
- Monitor and adapt to evolving Chinese regulatory requirements.
- Seek additional funding through private placements or shareholder support.
Key Dates
| Date | Description |
|---|---|
| 2026-01-01 | Beginning of the quarterly reporting period. |
| 2026-03-05 | Resignation of previous auditor, J&S Associate PLT. |
| 2026-03-20 | Engagement of new auditor, BZ CPA Inc. |
| 2026-03-31 | End of the quarterly reporting period. |
| 2026-05-15 | Filing date of the Form 10-Q. |
Recommendation
sellThe company exhibits classic signs of financial distress, including a lack of meaningful revenue, a significant working capital deficit, and reliance on related-party funding, making it a high-risk investment.
Keywords
China Foods Holdings, CFOO, Health and Wellness, 10-Q, China Operations, Micro-cap
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.